We are live on ! Find out more
GT

Greenleaf Trust Portfolio holdings

AUM $10.4B
1-Year Est. Return 0.97%
This Fund
S&P 500
This Quarter Est. Return
-11.99%
1 Year Est. Return
+0.97%
3 Year Est. Return
+37.24%
5 Year Est. Return
+56.69%
10 Year Est. Return
+246.06%
AUM
$5.06B
AUM Growth
-$474M
Cap. Flow
+$200M
Cap. Flow %
3.95%
Top 10 Hldgs %
85.86%
Holding
578
New
47
Increased
230
Reduced
158
Closed
88

Top Sells

Rank Stock Value
1
SYK icon
Stryker
SYK
+$20M
2
MSFT icon
Microsoft
MSFT
+$5.31M
3
WEN icon
Wendy's
WEN
+$3.58M
4
AAP icon
Advance Auto Parts
AAP
+$2.92M
5
SYF icon
Synchrony
SYF
+$1.65M

Sector Composition

Rank Sector Weight
1 Healthcare 72.37%
2 Financials 2.27%
3 Technology 2.26%
4 Consumer Discretionary 1.39%
5 Consumer Staples 1.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OZK icon
351
Bank OZK
OZK
$5.63B
$320K 0.01%
+14,022
New +$389K
BHC icon
352
Bausch Health
BHC
$1.75B
$318K 0.01%
17,234
+29
+0.2% +$690
TAL icon
353
TAL Education Group
TAL
$6.04B
$317K 0.01%
11,882
-3,770
-24% -$100K
DTE icon
354
DTE Energy
DTE
$29.9B
$316K 0.01%
3,366
+594
+21% +$58K
XLB icon
355
State Street Materials Select Sector SPDR ETF
XLB
$8.72B
$312K 0.01%
12,356
-7,504
-38% -$200K
LECO icon
356
Lincoln Electric
LECO
$14.1B
$311K 0.01%
3,946
+556
+16% +$46.1K
ADI icon
357
Analog Devices
ADI
$172B
$308K 0.01%
3,586
+802
+29% +$69.4K
BRK.A icon
358
Berkshire Hathaway Class A
BRK.A
$1.1T
$306K 0.01%
1
CIM
359
Chimera Investment
CIM
$1.06B
$306K 0.01%
5,723
GOVT icon
360
iShares US Treasury Bond ETF
GOVT
$43.7B
$306K 0.01%
12,430
IFF icon
361
International Flavors & Fragrances
IFF
$20.3B
$305K 0.01%
2,275
+327
+17% +$45.3K
MET icon
362
MetLife
MET
$62.4B
$305K 0.01%
7,418
+2,242
+43% +$96.2K
MGA icon
363
Magna International
MGA
$18.8B
$305K 0.01%
6,705
-3,835
-36% -$186K
YUMC icon
364
Yum China
YUMC
$15.7B
$302K 0.01%
9,002
NOC icon
365
Northrop Grumman
NOC
$76B
$301K 0.01%
1,230
+374
+44% +$103K
TT icon
366
Trane Technologies
TT
$98.8B
$300K 0.01%
3,290
+455
+16% +$44.7K
VRTX icon
367
Vertex Pharmaceuticals
VRTX
$123B
$300K 0.01%
1,808
+140
+8% +$24.3K
XLU icon
368
State Street Utilities Select Sector SPDR ETF
XLU
$23.1B
$297K 0.01%
11,240
-530
-5% -$14.4K
EPC icon
369
Edgewell Personal Care
EPC
$1.3B
$294K 0.01%
7,884
-1,892
-19% -$82.5K
WMB icon
370
Williams Companies
WMB
$85.8B
$294K 0.01%
13,332
+3,268
+32% +$81.7K
ALL icon
371
Allstate
ALL
$70.6B
$293K 0.01%
3,545
-1,194
-25% -$107K
APD icon
372
Air Products & Chemicals
APD
$65.5B
$293K 0.01%
1,829
+499
+38% +$79.1K
NTR icon
373
Nutrien
NTR
$33.9B
$287K 0.01%
6,105
-215
-3% -$11.2K
TEAM icon
374
Atlassian
TEAM
$26.5B
$286K 0.01%
3,214
+404
+14% +$32K
SRRA
375
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$285K 0.01%
5,404

Similar funds

Greenleaf Trust's Q4 2018 Portfolio in Review

As of Q4 2018, Greenleaf Trust held 578 positions worth $5.06B, down 8.6% from $5.53B the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Greenleaf Trust deployed $200M of net new capital in Q4 2018, opening 47 new positions and adding to 230 existing holdings. Its largest new stake was iShares Intermediate Government/Credit Bond ETF: 451,781 shares worth $48.9M.

By sector, the portfolio is most concentrated in Healthcare at 72% of assets, down from 75% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Stryker, an estimated $20M trimmed.

  • Greenleaf Trust's largest Q4 2018 buy was iShares Intermediate Government/Credit Bond ETF: 451,781 shares worth $48.9M.
  • Greenleaf Trust added most to iShares MSCI EAFE ETF in Q4 2018, an estimated $92.2M increase.
  • Greenleaf Trust's biggest Q4 2018 reduction was Stryker, cutting an estimated $20M.
  • Greenleaf Trust fully exited Praxair Inc in Q4 2018, selling an estimated $1.58M.
  • Greenleaf Trust's ten largest holdings make up 86% of its $5.06B portfolio in Q4 2018.
  • Greenleaf Trust opened 47 new positions and closed 88 in Q4 2018.
  • Greenleaf Trust's portfolio value fell 8.6% quarter-over-quarter to $5.06B.

Based on Greenleaf Trust's 13F filing for Q4 2018, filed 7 Feb 2019.